Exact Sciences Announces Preliminary Fourth Quarter 2020 Results
- Expected total revenue of $464.5-467.5M, including Screening revenue of $249-250M, Precision Oncology revenue of $117-118M, and COVID-19 testing revenue of $98.5-99.5M
News provided by
Share this article
Share this article
MADISON, Wis., Jan. 10, 2021 /PRNewswire/ Exact Sciences Corp. (Nasdaq: EXAS) today announced that the company expects to report revenue between $464.5 million and $467.5 million for the fourth quarter ended Dec. 31, 2020. I m incredibly proud of how the Exact Sciences team came together during 2020 to make progress towards our mission of eradicating cancer and the suffering it causes, said Kevin Conroy, chairman and CEO of Exact Sciences. Following our combination with Thrive, we are confident in making blood-based, multi-cancer screening a reality and being a leading provider of earlier, smarter cancer tests for patients at every step of their journey. We ve never been more excited abo
ResearchAndMarkets.com’s offering.
This ‘AL Amyloidosis – Market Insights, Epidemiology, and Market Forecast – 2030’ report delivers an in-depth understanding of the AL amyloidosis, historical and forecasted epidemiology as well as the market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan.
The AL Amyloidosis market report provides current treatment practices, emerging drugs, and their market share of the individual therapies, current and forecasted AL amyloidosis symptoms market size from 2017 to 2030 segmented by seven major markets. The report also covers current AL amyloidosis symptoms treatment practice/algorithm, market drivers, market barriers, and unmet medical needs to curate the best of the opportunities and assesses the underlying potential of the market.
Immune Checkpoint Inhibitors Improve Survival in Non−Small Cell Lung Cancer pharmacytimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmacytimes.com Daily Mail and Mail on Sunday newspapers.
PHOTO: REUTERS/NJERI MWANGI
The COVID-19 pandemic has had a major impact on cancer prevention and control in Africa, with immediate and anticipated long-term ramifications. The pandemic reached Africa when the continent was already struggling to deal with a growing cancer crisis, epitomized by more than 1 million new cancer cases and ∼700,000 deaths from cancer per year across Africa (
1). The response to COVID-19 immediately exacerbated the challenges in oncology at different levels including prevention, treatment, and palliative care and will undoubtedly result in increased late-stage presentation of cancer and a surge in mortality. Meanwhile, efforts to address these challenges have highlighted key opportunities where greater investment could substantially increase access to care and avail global oncology.
State bill eliminates barriers to treatment for Stage IV Cancer patients northwestsignal.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from northwestsignal.net Daily Mail and Mail on Sunday newspapers.